NCT05233956View on ClinicalTrials.gov

Levonorgestrel Intrauterine System Effects on Hemoglobin and Serum Ferritin Among Anemic Women in Kenya

NARecruitingINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

October 23, 2023

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Anemia
Interventions
DEVICE

LNG IUS

Avibela®: Levonorgestrel intrauterine system (LNG IUS) containing 52mg of LNG, released in the uterine cavity at approximately 19mcg per day.

DRUG

COCs

FemiplanTM: Combined oral contraceptives in a 21/7 pill package (21 pills of 0.15 mg of LNG and 30 mcg of EE followed by 7 pills containing 75 mg of ferrous fumarate).

Trial Locations (1)

Unknown

RECRUITING

Kangemi Health Center, Nairobi

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

FHI 360

OTHER